Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation
1999 StandoutNobel
Cutting Edge: Sustained Expansion of CD8+ T Cells Requires CD154 Expression by Th Cells in Acute Graft Versus Host Disease
1999
Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells
1999 StandoutNobel
CD40‐CD40 ligand interaction in autoimmune disease
1997
The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells
1998
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
1998 StandoutNature
Cleavable CD40Ig fusion proteins and the binding to sgp39
1995
Functions of CD40 on B cells, dendritic cells and other cells
1997
CD40 ligand-transduced co-stimulation of T cells in the development of helper function
1995 Nature
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study
2005
CD40 and its ligand in cell-mediated immunity
1998
Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR
2003
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
1999 StandoutNobel
WOMEN AND HIV
1997
CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance
2003
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
2005 StandoutNobel
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
1996
Murine AIDS requires CD154/CD40L expression by the CD4 T cells that mediate retrovirus-induced disease: Is CD4 T cell receptor ligation needed?
2006
Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
1996
In vivo effects of locally secreted IL-10 on the murine antitumor immune response
1996
Evidence for a Continued Requirement for CD40/CD40 Ligand (CD154) Interactions in the Progression of LP-BM5 Retrovirus-Induced Murine AIDS
1998
Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
1998
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
1998 StandoutNature
Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals
1996
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti‐CD154: A randomized, double‐blind, placebo‐controlled trial
2002
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
1996
Graves' Ophthalmopathy
2010 Standout
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
1997 StandoutNobel
PROLONGED SURVIVAL OF MOUSE SKIN ALLOGRAFTS IN RECIPIENTS TREATED WITH DONOR SPLENOCYTES AND ANTIBODY TO CD40 LIGAND1
1997
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
1999 Standout
CD40 and Its Ligand in Host Defense
1996
Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological tolerance
2003
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
2002 Standout
CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
1996
Role of interleukin 10 in specific immunotherapy.
1998 Standout
CD40 expression by human peripheral blood eosinophils.
1996
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
T Cells of Lupus and Molecular Targets for Immunotherapy
1997
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
2001 Standout
CD40-deficient mice infected with the defective murine leukemia virus LP-BM5def do not develop murine AIDS but produce IgE and IgG1in vivo
1999
T Cell Immunoglobulin Mucin-3 Crystal Structure Reveals a Galectin-9-Independent Ligand-Binding Surface
2007 StandoutNobel
Protective Role of CD40 in Leishmania major Infection at Two Distinct Phases of Cell-Mediated Immunity
1996
Costimulatory regulation of T cell function
1999 StandoutNobel
The CD40 pathway in allograft rejection, acceptance, and tolerance
1997
The TNF and TNF Receptor Superfamilies
2001 Standout
The Role of CD40 Ligand in Costimulation and T‐Cell Activation
1996
Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways
2003 StandoutNobel
The health and health system of South Africa: historical roots of current public health challenges
2009 Standout
Maternal mortality: who, when, where, and why
2006 Standout
CD40-Associated TRAF 6 Signaling Is Required for Disease Induction in a Retrovirus-Induced Murine Immunodeficiency
2004
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor
1998 StandoutNobel
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Involvement of CD40 Ligand-CD40 and CTLA4-B7 Pathways in Murine Acute Graft-Versus-Host Disease Induced by Allogeneic T Cells Lacking CD28
1998
TRANCE, a TNF Family Member, Is Differentially Expressed on T Cell Subsets and Induces Cytokine Production in Dendritic Cells
1999 StandoutNobel
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+T cell responses
1999 StandoutNobel
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
2002 StandoutNobel
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
1997 StandoutNobel
CD40-CD40 ligand
2000
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
2001 StandoutNobel
Cytolytic CD8+ T Cells Directed against a Cryptic Epitope Derived from a Retroviral Alternative Reading Frame Confer Disease Protection
2006
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation
1999 StandoutNobel
Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
2000 StandoutNobel
Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development
2001 StandoutNobel
Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.
1996
Dendritic cells require maturation via CD40 to generate protective antitumor immunity.
1998
Osteopontin augments CD3-mediated interferon-γ and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells
2000
Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease
2002
Lineage-Restricted Function of Nuclear Factor κB–Inducing Kinase (Nik) in Transducing Signals via Cd40
2000 StandoutNobel
Induction of immunological tolerance to islet allografts
1996
Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice
2010 StandoutNobel
IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
1996
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10
2000
Characterization of the CD154-Positive and CD40-Positive Cellular Subsets Required for Pathogenesis in Retrovirus-Induced Murine Immunodeficiency
2001
Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease
2002
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
2007 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
The anatomy of T-cell activation and tolerance.
1996
CD19 Signaling Pathways Play a Major Role for Murine AIDS Induction and Progression
2002
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
Possible Role of Interleukin-10 (IL-10) and CD40 Ligand Expression in the Pathogenesis of Hypergammaglobulinemia in Human Immunodeficiency Virus Infection: Modulation of IL-10 and Ig Production After Intravenous Ig Infusion
1998
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.
1995
T Cell Accumulation in B Cell Follicles Is Regulated by Dendritic Cells and Is Independent of B Cell Activation
2003
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
2000 StandoutNobel
The Role of CD4 T Cells in the Pathogenesis of Murine AIDS
2006
Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells.
2000
The CD154/CD40 Interaction Required for Retrovirus-Induced Murine Immunodeficiency Syndrome Is Not Mediated by Upregulation of the CD80/CD86 Costimulatory Molecules
2002
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
1998
Possible Role of Interleukin-10 (IL-10) and CD40 Ligand Expression in the Pathogenesis of Hypergammaglobulinemia in Human Immunodeficiency Virus Infection: Modulation of IL-10 and Ig Production After Intravenous Ig Infusion
1998
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
CD4+ T Cell Responses to CD40-Deficient APCs: Defects in Proliferation and Negative Selection Apply Only with B Cells as APCs
1999
The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells
1998
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL
2002 StandoutNobel
Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation
2005 StandoutNobel
Cutting Edge: Dendritic Cells Require Maturation via CD40 to Generate Protective Antitumor Immunity
1998
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of K M Crassi being referenced
Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.
1994
In the absence of a CD40 signal, B cells are tolerogenic
1995
Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice
1996
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause.
1997
Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency
1994